NCT00001977

Data

{
  "briefSummary": "This study will examine whether enhancing the chemical acetylcholine in the brain can improve memory and attention. It will identify changes in brain function that occur during these cognitive tasks. Animal and human studies have shown that a decrease in acetylcholine may be responsible for some of the cognition deficits in Alzheimer's disease. Conversely, patients taking medications that slow the breakdown of this neurotransmitter have experienced improvements in memory.\n\nNormal volunteers and patients with Alzheimer's disease may be eligible for this study of functional brain imaging using positron emission tomography (PET) and magnetic resonance imaging (MRI). These techniques can measure brain activity and identify brain regions involved in memory and attention. Candidates for this study will be screened with a medical and psychiatric history and a physical examination including blood tests, urinalysis, chest X-ray, and electrocardiogram (ECG). Those enrolled will perform memory and attention tasks during PET and MRI studies. The cognition tasks will be repeated twice-once during infusion of saline (a fluid with no drug effect) through a catheter inserted into a blood vessel and again during infusion of physostigmine, a drug that delays the breakdown of acetylcholine. The PET procedure will be completed in one day; the MRI procedure will be done on two different days.\n\nDuring imaging, attention and memory tasks will be presented in short blocks of about 4-minutes duration. They will be repeated in sequence up to 10 times with a few minutes separation. Subjects will be shown pictures of faces or other visual stimuli and asked to decide whether the pictures are the same or different.\n\nInformation gained from this study may increase knowledge about how acetylcholine affects the brain's response to memory and attention tasks and perhaps lead to better treatments for the cognitive deficits in Alzheimer's disease.",
  "completionDate": "2001-04",
  "conditions": [
    "Alzheimer's Disease",
    "Healthy"
  ],
  "enrollmentCount": 70,
  "enrollmentType": null,
  "nctId": "NCT00001977",
  "phase": null,
  "sponsorId": "national-institute-of-mental-health-nimh",
  "startDate": "2000-01",
  "status": "COMPLETED",
  "studyType": "OBSERVATIONAL",
  "title": "Cholinergic Modulation of Human Memory and Attention: Functional Neuroimaging Studies",
  "url": "https://clinicaltrials.gov/study/NCT00001977"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version